Telemedicine Education for Type 1 Diabetes

(TREAT-ED Trial)

Overseen by Ingrid Libman, MD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Pittsburgh

No Placebo Group

Trial Summary

What is the purpose of this trial?

Emerging adults with type 1 diabetes are a vulnerable population. While diabetes self-management and education is known to offer opportunities to develop self-management skills required to achieve and maintain short- and long-term diabetes outcomes, emerging adults are reported to have poor clinic attendance and in turn low participation in diabetes self-management education and support services. This pilot study aims to test a novel approach to diabetes self-management education and support that incorporates technological and applied learning-driven methods delivered through group telemedicine visits to improve emerging adults engagement in diabetes self-management education and support with the ultimate goal of improving diabetes outcomes.

Research Team

Ingrid Libman, MD

Principal Investigator

University of Pittsburgh

Linda Siminerio, RN, PhD, CDCES

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for emerging adults with Type 1 Diabetes who may struggle to attend clinic appointments. It's designed to help them learn and manage their diabetes better using group telemedicine sessions.

Inclusion Criteria

Able to communicate via videoconferencing platform

Intending to maintain status as a patient at participating clinical sites throughout the study duration

Able to provide informed consent

Exclusion Criteria

I do not have type 1 diabetes.

I am either younger than 18 or older than 25 years old.

Do not intend to maintain their care at participating clinical sites throughout the duration of the study

Treatment Details

Interventions

• TREAT-ED Virtual Group Diabetes Self-Management Education and Support (Behavioural Intervention)

Trial Overview The study tests a new method called TREAT-ED, which uses virtual group meetings for diabetes self-management education and support, aiming to improve engagement and overall diabetes outcomes.

Participant Groups

Group I: TREAT-ED Experimental Treatment 1 Intervention

* Emerging adult patients with type 1 diabetes assigned to groups of eight participants on average. * Four diabetes self-management education and support group sessions delivered virtually each session lasting 30-45 minutes. * Group sessions scheduled at intervals decided up on by participants.

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials

1,820

Recruited

16,360,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2,513

Recruited

4,366,000+